NCT05985200View on ClinicalTrials.gov

A Study in Healthy People to Test How Well Repeated Doses of BI 3032950 Are Tolerated

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 15, 2023

Primary Completion Date

August 19, 2024

Study Completion Date

August 19, 2024

Conditions
Healthy
Interventions
DRUG

BI 3032950

BI 3032950

DRUG

Placebo matching BI 3032950

Placebo matching BI 3032950

Trial Locations (1)

2650

SGS Life Science Services - Clinical Research, Edegem

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05985200 - A Study in Healthy People to Test How Well Repeated Doses of BI 3032950 Are Tolerated | Biotech Hunter | Biotech Hunter